Ads
related to: keytruda cancer drug price- ENHERTU® Safety Info
Important Side Effect Information
for Patients and Caregivers.
- ENHERTU® Information
Learn More About ENHERTU® and How
it is Thought to Work.
- ENHERTU® Data
Access Important Data on How
ENHERTU® Performed in Studies.
- ENHERTU® Resources
Access Free Patient Resources Like
a Downloadable Brochure.
- ENHERTU® Safety Info
Search results
Merck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Benzinga via Yahoo Finance· 2 days agoTuesday, Merck & Co Inc (NYSE:MRK) released topline data from hase 3 KEYNOTE-522 trial of Keytruda...
Merck is spending $3 billion on an eye drug developer as it braces to lose a key cancer patent
Quartz· 1 day agoPharma giant Merck said on Wednesday that it is acquiring the privately-held eye drug developer...
Health Care Roundup: Market Talk
The Wall Street Journal· 3 hours agoGoldman Sachs initiates Roche’s rating at sell with at a target price of CHF236. Share trade 0.6% lower at CHF228.20. (helena.smolak@wsj.com) 0003 ET –...
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
Benzinga via Yahoo Finance· 6 days agoKeytruda (pembrolizumab) is Merck & Co Inc’s (NYSE:MRK) top selling cancer drug. The abstract...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 6 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence - Merck & Co...
Benzinga· 2 days agoMerck & Co., Inc. MRK is reportedly on the verge of acquiring EyeBio, an eye drug company, for a sum...
Iovance (IOVA) Up 5% on Updated Data From Melanoma Study
Zacks· 7 days agoFree Report) announced updated clinical results from a cohort of the phase II IOV-COM-202 study evaluating the combination of its recently approved cell therapy Amtagvi and Merck’s blockbuster ...
Hedge Funds Are Loading Up On This Dividend Stock
Benzinga via Yahoo Finance· 3 days agoThe markets are adjusting to the high interest rates environment, with all the major US stock indices reporting strong gains in May 2024. However, even...
News Highlights: Top Company News of the Day - Wednesday at 5 AM ET
Morningstar· 2 days agoBHP Seeks Another Extension to $50 Billion Takeover Talks With Anglo American BHP said a further deadline extension is needed before it can reach an agreement with Anglo American on a $50 billion takeover of its London-based rival. Royal Mail
Billionaire Ken Griffin Is Buying These Dividend Stocks Hand Over Fist. Should You?
Motley Fool via Yahoo Finance· 7 days agoThe company picked up new U.S. and European approvals for blockbuster drug Keytruda. It announced...
